SVA Sinovac Biotech Ltd.
Fundamentals / CIK 0001084201 / USDSinovac Biotech Ltd. reported $386.0M in revenue and a net loss of $59.68M for the fiscal year ended December 31, 2025 (up 6.8% year over year), with a 67.9% gross margin and a -127.0% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SVA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$386.0M +6.8% YoY
-
Operating Income FY 2025-$490.1M -127.0% margin
-
Net Income FY 2025-$59.68M -15.5% net margin
-
Diluted EPS FY 2025-$0.83 Split-adjusted
-
Free Cash Flow FY 2025-$561.1M -145.4% FCF margin
-
Cash & ST Investments Dec 31, 2025$5.97B Total debt: $505.6M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $386.0M | $361.4M | $470.2M | $1.47B | $19.37B | $510.6M | $246.1M | $229.7M | $174.3M | $72.43M |
| Cost of Revenue | $124.0M | $140.7M | $146.9M | $658.2M | $988.9M | $67.18M | $32.47M | $24.72M | $20.24M | $22.39M |
| Gross Profit | $262.0M | $220.7M | $323.3M | $815.2M | $18.38B | $443.4M | $213.6M | $204.9M | $154.1M | $50.04M |
| Research & Development | $216.2M | $270.7M | $350.2M | $478.7M | $152.7M | $48.76M | $24.25M | $21.91M | $20.49M | $12.65M |
| Selling, General & Admin | $333.0M | $420.9M | $598.2M | $836.1M | $602.1M | $176.5M | $121.5M | $137.0M | $87.36M | $41.98M |
| Total Operating Expenses | $752.1M | $726.2M | $1.04B | $1.32B | $758.1M | $227.8M | $145.0M | $159.6M | $108.7M | $49.53M |
| Operating Income | -$490.1M | -$505.5M | -$714.0M | -$509.0M | $17.62B | $215.6M | $68.56M | $45.32M | $45.42M | $504K |
| EBITDA | -$391.4M | -$394.3M | -$555.5M | -$355.8M | $17.70B | $219.4M | $73.14M | $50.20M | $50.05M | $5.57M |
| Interest Income | $33.28M | $29.07M | $87.12M | $157.4M | $102.6M | $1.93M | $2.00M | $2.02M | $1.18M | $731K |
| Interest Expense | $9.82M | $5.64M | $4.94M | $1.26M | $2.84M | $1.45M | $650K | $1.07M | $1.57M | $1.73M |
| Income Before Tax | -$262.1M | $42.84M | -$84.49M | -$48.48M | $17.57B | $216.6M | $70.82M | $46.58M | $45.04M | -$394K |
| Income Tax Expense | -$63.27M | $2.18M | $36.37M | $11.48M | $3.45B | $31.44M | $5.61M | $10.47M | $8.34M | $2.66M |
| Net Income | -$59.68M | $90.91M | -$13.49M | $14.47M | $8.12B | $110.4M | $44.93M | $21.78M | $25.81M | -$596K |
| Basic EPS | -$0.83 | $1.27 | -$0.19 | $0.20 | $113.54 | $2.34 | $0.93 | $0.75 | $0.99 | -$0.02 |
| Diluted EPS | -$0.83 | $1.27 | -$0.19 | $0.20 | $113.44 | $2.14 | $0.91 | $0.75 | $0.99 | -$0.02 |
| Basic Shares Outstanding | 71.9M | 71.9M | 71.8M | 71.7M | 71.5M | 44.7M | 42.9M | 29.3M | 25.8M | 25.8M |
| Diluted Shares Outstanding | 71.9M | 71.9M | 71.9M | 71.8M | 71.6M | 51.4M | 49.6M | 29.4M | 25.8M | 25.8M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $488.2M | $335.3M | $1.12B | $3.88B | $11.61B | $1.04B | $152.7M | $158.2M | $114.4M | $62.43M |
| Short-Term Investments | $5.48B | $9.61B | $9.89B | $6.65B | $1.81B | $135.2M | $50.27M | $18.91M | -- | -- |
| Cash & Short-Term Investments | $5.97B | $9.95B | $11.02B | $10.53B | $13.42B | $1.18B | $203.0M | $177.1M | $114.4M | $62.43M |
| Accounts Receivable, Net | $286.3M | $300.9M | $424.9M | $486.6M | $942.7M | $253.5M | $113.7M | $74.46M | $66.20M | $49.83M |
| Inventory | $94.31M | $96.92M | $135.6M | $175.3M | $391.1M | $105.8M | $27.85M | $25.09M | $19.62M | $14.10M |
| Total Current Assets | $7.06B | $10.64B | $11.60B | $11.30B | $14.94B | $1.56B | $349.6M | $284.2M | $203.9M | $130.7M |
| Property, Plant & Equipment, Net | $706.1M | $881.0M | $952.0M | $989.7M | $855.0M | $200.4M | $74.31M | $70.92M | $76.43M | $66.88M |
| Goodwill | $12.60M | $27.51M | $0 | $0 | $0 | -- | -- | -- | -- | -- |
| Intangible Assets | $77.68M | $122.6M | $8.52M | $9.70M | $1.48M | $1.47M | -- | -- | -- | -- |
| Long-Term Investments | $512.3M | $491.3M | $879.8M | $1.43B | $655.8M | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $18.28M | $20.49M | $20.91M | $19.21M | $1.61M | -- | -- | -- | $528K | $964K |
| Total Non-Current Assets | $1.48B | $1.69B | $2.01B | $2.73B | $1.82B | $341.0M | $102.7M | $85.61M | $95.33M | $80.61M |
| Total Assets | $8.54B | $12.34B | $13.61B | $14.03B | $16.76B | $1.90B | $452.3M | $369.8M | $299.2M | $211.4M |
| Accounts Payable | $16.23M | $12.25M | $12.95M | $19.88M | $58.47M | $30.54M | $5.78M | $5.53M | $6.78M | $1.83M |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | $3.32M | $18.15M | $31.28M |
| Deferred Revenue (Current) | $11.27M | $12.21M | $27.05M | $25.54M | $79.72M | $363.8M | $5.46M | $2.91M | $4.07M | $2.77M |
| Total Current Liabilities | $1.54B | $1.45B | $1.29B | $1.26B | $2.52B | $679.6M | $87.20M | $58.20M | $92.54M | $66.26M |
| Long-Term Debt | $494.9M | $375.8M | $253.9M | $11.81M | $15.77M | $35.10M | $5.93M | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | $0 | $200K | $206K | $223K | -- | $0 | $90K | $0 | $89K |
| Other Non-Current Liabilities | $24K | $23K | $40K | $35K | $319K | $865K | $1.73M | $3.00M | $3.14M | $2.94M |
| Total Non-Current Liabilities | $605.1M | $592.0M | $676.8M | $530.8M | $687.0M | $101.6M | $12.90M | $19.65M | $29.54M | $15.43M |
| Total Liabilities | $2.15B | $2.04B | $1.97B | $1.79B | $3.21B | $781.2M | $100.1M | $77.85M | $122.1M | $81.69M |
| Total Debt (incl. Leases) | $505.6M | $391.3M | $299.0M | $70.31M | $138.6M | $124.1M | $12.23M | $7.21M | $33.00M | $40.73M |
| Common Stock | $72K | $72K | $72K | $72K | $72K | $99K | $99K | $71K | $57K | $57K |
| Retained Earnings | $2.82B | $6.84B | $6.79B | $6.80B | $6.81B | $144.2M | $56.73M | $23.82M | $9.13M | -$11.91M |
| Accumulated Other Comp. Income | -$513.3M | -$707.8M | -$563.4M | -$401.3M | $129.5M | $19.93M | -$4.32M | -$2.10M | $7.08M | $168K |
| Total Stockholders' Equity | $4.44B | $8.26B | $8.32B | $8.49B | $9.00B | $746.5M | $294.0M | $253.4M | $151.2M | $115.8M |
| Total Equity | $6.40B | $10.29B | $11.64B | $12.24B | $13.55B | $1.13B | $352.2M | $291.9M | $177.1M | $129.7M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $488.2M | $335.3M | $1.12B | $3.88B | $11.61B | $1.04B | $152.7M | $158.2M |
| Short-Term Investments | $5.48B | $9.61B | $9.89B | $6.65B | $1.81B | $135.2M | $50.27M | $18.91M |
| Cash & Short-Term Investments | $5.97B | $9.95B | $11.02B | $10.53B | $13.42B | $1.18B | $203.0M | $177.1M |
| Accounts Receivable, Net | $286.3M | $300.9M | $424.9M | $486.6M | $942.7M | $253.5M | $113.7M | $74.46M |
| Inventory | $94.31M | $96.92M | $135.6M | $175.3M | $391.1M | $105.8M | $27.85M | $25.09M |
| Total Current Assets | $7.06B | $10.64B | $11.60B | $11.30B | $14.94B | $1.56B | $349.6M | $284.2M |
| Property, Plant & Equipment, Net | $706.1M | $881.0M | $952.0M | $989.7M | $855.0M | $200.4M | $74.31M | $70.92M |
| Goodwill | $12.60M | $27.51M | $0 | $0 | $0 | -- | -- | -- |
| Intangible Assets | $77.68M | $122.6M | $8.52M | $9.70M | $1.48M | $1.47M | -- | -- |
| Long-Term Investments | $512.3M | $491.3M | $879.8M | $1.43B | $655.8M | -- | -- | -- |
| Other Non-Current Assets | $18.28M | $20.49M | $20.91M | $19.21M | $1.61M | -- | -- | -- |
| Total Non-Current Assets | $1.48B | $1.69B | $2.01B | $2.73B | $1.82B | $341.0M | $102.7M | $85.61M |
| Total Assets | $8.54B | $12.34B | $13.61B | $14.03B | $16.76B | $1.90B | $452.3M | $369.8M |
| Accounts Payable | $16.23M | $12.25M | $12.95M | $19.88M | $58.47M | $30.54M | $5.78M | $5.53M |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | $3.32M |
| Deferred Revenue (Current) | $11.27M | $12.21M | $27.05M | $25.54M | $79.72M | $363.8M | $5.46M | $2.91M |
| Total Current Liabilities | $1.54B | $1.45B | $1.29B | $1.26B | $2.52B | $679.6M | $87.20M | $58.20M |
| Long-Term Debt | $494.9M | $375.8M | $253.9M | $11.81M | $15.77M | $35.10M | $5.93M | -- |
| Deferred Revenue (Non-Current) | -- | $0 | $200K | $206K | $223K | -- | $0 | $90K |
| Other Non-Current Liabilities | $24K | $23K | $40K | $35K | $319K | $865K | $1.73M | $3.00M |
| Total Non-Current Liabilities | $605.1M | $592.0M | $676.8M | $530.8M | $687.0M | $101.6M | $12.90M | $19.65M |
| Total Liabilities | $2.15B | $2.04B | $1.97B | $1.79B | $3.21B | $781.2M | $100.1M | $77.85M |
| Total Debt (incl. Leases) | $505.6M | $391.3M | $299.0M | $70.31M | $138.6M | $124.1M | $12.23M | $7.21M |
| Common Stock | $72K | $72K | $72K | $72K | $72K | $99K | $99K | $71K |
| Retained Earnings | $2.82B | $6.84B | $6.79B | $6.80B | $6.81B | $144.2M | $56.73M | $23.82M |
| Accumulated Other Comp. Income | -$513.3M | -$707.8M | -$563.4M | -$401.3M | $129.5M | $19.93M | -$4.32M | -$2.10M |
| Total Stockholders' Equity | $4.44B | $8.26B | $8.32B | $8.49B | $9.00B | $746.5M | $294.0M | $253.4M |
| Total Equity | $6.40B | $10.29B | $11.64B | $12.24B | $13.55B | $1.13B | $352.2M | $291.9M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$198.8M | $40.66M | -$120.9M | -$59.97M | $14.12B | $185.2M | $65.22M | $36.11M | $36.70M | -$720K |
| Depreciation & Amortization | $98.78M | $111.3M | $158.4M | $153.1M | $85.25M | $3.80M | $4.58M | $4.89M | $4.64M | $5.06M |
| Stock-Based Compensation | $0 | $0 | $0 | $0 | $7.74M | $10.20M | $3.00M | $4.30M | $979K | $2.41M |
| Change in Receivables | $24.27M | $87.73M | $41.41M | $389.9M | -$676.6M | -$128.0M | -$40.19M | -$13.08M | -$13.48M | -$15.12M |
| Change in Inventory | -$23.02M | -$665K | -$14.86M | $26.89M | -$325.1M | -$77.74M | -$3.65M | -$9.41M | -$5.53M | -$3.02M |
| Operating Cash Flow | -$512.2M | -$56.89M | $138.6M | -$798.1M | $15.32B | $479.3M | $39.07M | $7.94M | $59.76M | -$13.90M |
| Capital Expenditure | -$48.92M | -$95.96M | -$156.2M | -$313.9M | -$594.2M | -$127.5M | -$10.63M | -$5.61M | -$11.91M | -$12.65M |
| Free Cash Flow | -$561.1M | -$152.9M | -$17.52M | -$1.11B | $14.73B | $351.8M | $28.45M | $2.33M | $47.84M | -$26.56M |
| Acquisitions, Net | -$14.15M | -$100.2M | $0 | $0 | $0 | -- | -- | -- | -- | -- |
| Sales & Maturities of Investments | $10.67B | $5.59B | $2.51B | $19.71B | $4.74B | $124.6M | -- | -- | -- | -- |
| Investing Cash Flow | $4.39B | $456.4M | -$2.70B | -$6.09B | -$2.98B | -$204.8M | -$42.45M | -$25.26M | -$11.90M | -$11.78M |
| Common Stock Issued | $0 | $0 | $676K | $0 | $1.03M | $2.00M | $0 | $85.30M | $1.26M | $315K |
| Dividends Paid | -$3.53B | -$947.0M | -$328.1M | -$247.4M | -$1.88B | $0 | $0 | -- | -- | -- |
| Financing Cash Flow | -$3.43B | -$824.0M | -$88.55M | -$299.5M | -$1.91B | $592.6M | $1.74M | $64.18M | -$1.34M | $27.78M |
| Net Change in Cash | $554.2M | -$526.9M | -$2.76B | -$7.73B | $10.57B | $894.3M | -$2.29M | $42.21M | $50.52M | -$162K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.9% | 61.1% | 68.8% | 55.3% | 94.9% | 86.8% | 86.8% | 89.2% | 88.4% | 69.1% |
| Operating Margin | -127.0% | -139.9% | -151.9% | -34.5% | 91.0% | 42.2% | 27.9% | 19.7% | 26.0% | 0.7% |
| Net Profit Margin | -15.5% | 25.2% | -2.9% | 1.0% | 41.9% | 21.6% | 18.3% | 9.5% | 14.8% | -0.8% |
| Return on Equity (ROE) | -1.3% | 1.1% | -0.2% | 0.2% | 90.3% | 14.8% | 15.3% | 8.6% | 17.1% | -0.5% |
| Return on Assets (ROA) | -0.7% | 0.7% | -0.1% | 0.1% | 48.5% | 5.8% | 9.9% | 5.9% | 8.6% | -0.3% |
| Current Ratio | 4.59x | 7.33x | 8.97x | 9.00x | 5.93x | 2.30x | 4.01x | 4.88x | 2.20x | 1.97x |
| Quick Ratio | 4.53x | 7.26x | 8.87x | 8.86x | 5.78x | 2.14x | 3.69x | 4.45x | 1.99x | 1.76x |
| Debt to Equity | 0.11x | 0.05x | 0.04x | 0.01x | 0.02x | 0.17x | 0.04x | 0.03x | 0.22x | 0.35x |
| Revenue Growth (YoY) | +6.8% | -23.1% | -68.1% | -92.4% | +3692.5% | +107.5% | +7.1% | +31.7% | +140.7% | +7.4% |
| Gross Profit Growth (YoY) | +18.7% | -31.7% | -60.3% | -95.6% | +4044.0% | +107.6% | +4.2% | +33.0% | +208.0% | +2.1% |
| Operating Income Growth (YoY) | -- | -- | -- | -102.9% | +8070.1% | +214.5% | +51.3% | -0.2% | +8911.3% | -86.4% |
| Net Income Growth (YoY) | -165.7% | -- | -193.3% | -99.8% | +7259.1% | +145.7% | +106.3% | -15.6% | -- | -- |
| EPS Growth (YoY) | -165.4% | -- | -195.0% | -99.8% | +4745.3% | +152.4% | +23.5% | -24.4% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -141.0% | -- | -105.2% | +3096.7% | +1126.7% | +391.9% | -86.7% | -- | -430.1% |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -107.6% | +4086.1% | +1136.8% | +1120.9% | -95.1% | -- | -- |
| 5Y Revenue / Share Growth | -52.9% | -12.3% | -16.5% | +204.0% | +9528.2% | +331.3% | +129.5% | +173.4% | +241.2% | +22.2% |
| 10Y Revenue / Share Growth | +103.0% | +101.3% | +128.1% | +937.1% | +11664.7% | +720.3% | +31.2% | -- | -- | -- |
| 5Y Net Income / Share Growth | -133.7% | +20.8% | -125.2% | -79.8% | -- | -- | -- | +150.1% | -- | -- |
| 10Y Net Income / Share Growth | -- | -- | -163.1% | -- | -- | -- | +1.0% | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.